跳至主要内容
临床试验/NCT02961712
NCT02961712Unknown1 期

Immunotherapy of Natural Killer in HTLV-1 Associated Myelopathy

The Second Affiliated Hospital of Fujian Medical University1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2016年7月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
15
试验地点
1
主要终点
change of Osame's Motor Disability Score

研究概览

简要总结

HTLV-1 Associated Myelopathy is a chronic disease of the spinal cord, caused by a virus called human T lymphotropic virus type 1(HTLV-1). Natural Killer cells provide rapid responses to viral-infected cells, acting at around 3 days after infection, and respond to tumor formation. In this trial, the investigators aim to study the therapeutic safety and the effect on HTLV-1 virus. This in turn will improve the knowledge and understanding of the disease and should lead to better therapy.

详细描述

HAM is a chronic disease of the spinal cord, caused by a virus called HTLV-I. Natural Killer cells provide rapid responses to viral-infected cells, acting at around 3 days after infection, and respond to tumor formation. In this trial, the investigators aim to study the therapeutic safety and the effect on HTLV-1 virus. This in turn will improve the knowledge and understanding of the disease and should lead to better therapy.

In a single-center, one year open-label trial, 5 HAM patients will be treated with single intravenous injection of NK cells (0.9~1*10^9). Then, the the clinical effect was evaluated by dynamic analysis of Osame's Motor Disability Score and other related physiological indices, such as HTLV-1 antibody titer in blood and cerebrospinal fluid.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of HTLV-1 associated myelopathy

排除标准

  • HIV infection
  • Hepatitis B & C viral infections

结局指标

主要结局

change of Osame's Motor Disability Score

时间窗: 1 year

The score were defined as follows: 0, no disability; 1, walking slow; 2, a little trouble when walking; 3, unable to run; 4, needs guardrail while going up the stairs; 5, needs one hand support while walking; 6, needs two hands support while walking (\> 10 m); and 7, needs two hands support while walking (\< 10 m); 8, needs two hands support while walking (\< 5 m); 9, unable to walk but can crawl; 10, unable to crawl but can move; 11, unable to move but can roll over on the bed; 12 unable to roll over; 13, unable to flex toes

次要结局

  • HTLV-1 antibody titer in cerebrospinal fluid(1 year)
  • HTLV-1 antibody titer in serum(1 year)
  • HTLV-1 proviral load in blood(1 year)

研究者

发起方
The Second Affiliated Hospital of Fujian Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验